Brii Biosciences Limited provided updates on its diverse pipeline of infectious disease and central nervous system disease candidates and announced a pivotal leadership transition that will further advance its strategic priorities.
Brii Biosciences Limited provided updates on its diverse pipeline of infectious disease and central nervous system disease candidates and announced a pivotal leadership transition that will further advance its strategic priorities.